Literature DB >> 28859515

The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.

Takashi Murata1, Yuji Aoki2, Yasuhisa Kato3, Tsuyoshi Tanaka4, Rika Araki5, Ken Kato6, Kazuyuki Hida7, Tomokazu Kawamura8, Kazuya Yoshida8, Youichi Imamura8, Tetsushi Toyonaga8,9, Kazunori Yamada1, Naoki Sakane10.   

Abstract

Entities:  

Keywords:  Japan; continuous subcutaneous insulin infusion; insulin pump; multiple daily injections; type 1 diabetes mellitus

Mesh：

Substances：

Year:  2017        PMID： 28859515      PMCID： PMC5950985          DOI： 10.1177/1932296817697330

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  2 in total

1.  Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry.

Authors:  Jill H Simmons; Vincent Chen; Kellee M Miller; Janet B McGill; Richard M Bergenstal; Robin S Goland; David M Harlan; Joseph F Largay; Elaine M Massaro; Roy W Beck
Journal:  Diabetes Care       Date:  2013-09-11       Impact factor: 19.112

2.  The relationship between the frequency of self-monitoring of blood glucose and glycemic control in patients with type 1 diabetes mellitus on continuous subcutaneous insulin infusion or on multiple daily injections.

Authors:  Takashi Murata; Kokoro Tsuzaki; Fumi Yoshioka; Hiroshi Okada; Junichiro Kishi; Kazunori Yamada; Naoki Sakane
Journal:  J Diabetes Investig       Date:  2015-05-25       Impact factor: 4.232
  2 in total
  2 in total

1.  Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults' Glycemia in T1DM subanalysis.

Authors:  Norio Abiru; Akira Shimada; Rimei Nishimura; Munehide Matsuhisa; Asuka Ozaki; Hiroshi Ikegami
Journal:  Diabetol Int       Date:  2021-04-25

2.  Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan.

Authors:  Tasuku Okui; Chinatsu Nojiri; Shinichiro Kimura; Kentaro Abe; Sayaka Maeno; Masae Minami; Yasutaka Maeda; Naoko Tajima; Tomoyuki Kawamura; Naoki Nakashima
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-11       Impact factor: 2.796
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.